Tanveer Naseer

MAY 16, 2011

Russell is an educational psychologist, author, executive coach and management consultant whose clients include Fortune 500 executives in aerospace, healthcare, pharmaceutical and biotechnology, information technology, telecommunications and oil and gas. Obviously, it’s pretty easy to assail government bureaucracy, but how about industry?

Bureaucracy 232

Bureaucracy Compliance Learning-by-Doing Engineering 232

Harvard Business Review

FEBRUARY 16, 2016

However, outside North America they tend to be more optimistic about emerging economies: 36% of directors in Asia, 24% of directors in Australia and New Zealand, and 23% of directors in Africa predict faster growth in emerging economies than in developed countries in the next three years. Some findings were not terribly surprising.

Politics 8

Politics Telecommunications Policies Biotechnology 8

Harvard Business Review

OCTOBER 23, 2014

Energy, agriculture, insurance, retail, human resources — no industry is unaffected. That’s why pharmaceutical, biotechnology, and medical device companies need to define their relevance in this new health care ecosystem, and soon. Or lenders’ enhanced abilities to gauge credit risk. They’re also sharing risk. But not for long.

Health Care 8

Health Care Pharmaceuticals Information Technology Supply Chain 8